RxDoctor Payments DataLook up a doctor →

Neil Bressler, MD

Ophthalmology · Baltimore, MDNPI 1790742245

Payments from drug & device makers

$3,563,396in general payments, 2019–2025

Across 163 payments — averaging $21,861 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Regeneron$3.3M
  • Genentech, Inc.$146K
  • Bayer$26K
  • Amgen$21K
  • Biogen$21K
  • Novartis$10K
  • plus $25K from 5 others
$23,046in research payments, 2019–2025

Across 12 payments — averaging $1920.46 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • F. Hoffmann-la Roche AG$22K
  • Regeneron$893

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$3,563,396 in reported general payments places this provider in the 95th percentile of 493 ophthalmology providers in Maryland.

See all ophthalmology providers in Maryland

Medicare billing

Part B allowed, 2024
$446,837
Medicare patients
272
Services billed
1,974

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other ophthalmology in Baltimore

See the full list for Maryland

Where these figures come from

Is this you, or does something look wrong? →